| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | LYK98WP91F |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Programmed cell death protein 1 inhibitor | Other Other ClinicalTrials |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Urinary Bladder Neoplasms | 3 | D001749 | ClinicalTrials |
| Urinary Bladder Neoplasms | 3 | D001749 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298001 |
| FDA SRS | LYK98WP91F |
CONTENTS